Reducing the growing burden of cardiovascular disease in the developing world

被引:190
作者
Gaziano, Thomas A. [1 ]
机构
[1] Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Social Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1377/hlthaff.26.1.13
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Cardiovascular disease (CVD) has become the number-one cause of death in the developing world. This epidemic has the potential to place a large social and economic burden on developing countries, where CVD tends to strike those in their prime working years. Since resources for managing CVD are limited, it is important that interventions be guided by cost-effectiveness results for low- and middle-income countries. Despite the burden, cost-effective strategies exist at the population and individual levels for reducing CVD. Integral to all personal intervention strategies is an adequate assessment of the underlying risk of disease.
引用
收藏
页码:13 / 24
页数:12
相关论文
共 34 条
  • [1] *AM HEART ASS, 2003, HEART DIS STROK STAT
  • [2] [Anonymous], CARDIOVASCULAR DIS D
  • [3] [Anonymous], 2002, World Development Indicators
  • [4] [Anonymous], 2001, MACROECONOMICS HLTH
  • [5] [Anonymous], 2003, WORLD HLTH REPORT 20
  • [6] BATUSSEN RM, 2002, GEN COST EFFECTIVENE
  • [7] Atenolol in hypertension: is it a wise choice?
    Carlberg, B
    Samuelsson, O
    Lindholm, LJ
    [J]. LANCET, 2004, 364 (9446) : 1684 - 1689
  • [8] Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P469
  • [9] Chaloupka F. J., 2000, TAXATION TOBACCO PRO
  • [10] Cardiovascular disease in the developing world and its cost-effective management
    Gaziano, TA
    [J]. CIRCULATION, 2005, 112 (23) : 3547 - 3553